Fusemachines Inc. (NASDAQ: FUSE), a leading provider of enterprise AI products and services, today announced that existing investor Meteora Capital has made ...
Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies ...